Antibiotic Prescribing May Delay Diagnosis of Head and Neck Cancer
(MedPage Today) -- Antibiotics are often prescribed in the 3 months preceding a diagnosis of head and neck cancer, resulting in delays in diagnosis, according to a large retrospective cohort study. In over 7,800 patients with head and neck cancer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 24, 2023 Category: Hematology Source Type: news

Chemoimmunotherapy Safe, Effective for Untreated Lung Cancer Brain Metastases
(MedPage Today) -- Chemoimmunotherapy for untreated lung cancer brain metastases delayed progression and use of whole-brain radiation, a prospective phase II study showed. Atezolizumab (Tecentriq) plus carboplatin and pemetrexed led to a 12-week... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 24, 2023 Category: Hematology Source Type: news

Chemo Shortage Fuels Price Gouging; MDS Misdiagnoses; Risky Accelerated Approvals?
(MedPage Today) -- The shortage of key chemotherapy drugs has led to price gouging, forcing some hospitals to pay as much as 10 times the usual cost. (NBC News) The shortage of carboplatin disproportionately affects patients with ovarian cancer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 18, 2023 Category: Hematology Source Type: news

Clot Risk Factors Emerge for Cancer Patients With COVID-19
(MedPage Today) -- Multiple factors were associated with an increased risk for venous thromboembolism (VTE) in hospitalized cancer patients with COVID-19, a registry-based cohort study found. Pooled together, exposure to commonly used anti-cancer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 17, 2023 Category: Hematology Source Type: news

Higher BMI = Less Neutropenia With CDK4/6 Inhibitor for Early Breast Cancer
(MedPage Today) -- A higher body mass index (BMI) translated into less neutropenia and fewer discontinuations among women with early hormone receptor (HR)-positive breast cancer treated with a CDK4/6 inhibitor, a secondary analysis of the randomized... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 12, 2023 Category: Hematology Source Type: news

First-in-Class Drug Approved for Heavily Pretreated Myeloma
(MedPage Today) -- The FDA granted accelerated approval to talquetamab (Talvey) for treating adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, drug developer Janssen announced Thursday... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 10, 2023 Category: Hematology Source Type: news

'Critically Impactful' Drug Shortages; Emotions and Cancer; CRC Clues in Microbiome
(MedPage Today) -- In a recent survey, almost a third of healthcare system pharmacists said drug shortages are "critically impacting" patient care. (CNN) Six months of aerobic exercise helped reduce chemotherapy-induced peripheral neuropathy among... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 10, 2023 Category: Hematology Source Type: news

Certain Medications Tied to Post-COVID Pulmonary Fibrosis
(MedPage Today) -- Pre-infection exposures to rituximab (Rituxan) or chemotherapy were associated with an increased incidence of pulmonary fibrosis in adults hospitalized for COVID-19, a nationwide cohort study suggested. Incidence of a new pulmonary... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 8, 2023 Category: Hematology Source Type: news

In a Golden Age of Cancer Care, PBMs Are Holding Us Back
(MedPage Today) -- *Patient name has been changed We're living in a remarkable time for cancer treatment, when a diagnosis no longer disrupts how patients live and work. Unlike years ago, an advanced cancer diagnosis is no longer a death sentence... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 5, 2023 Category: Hematology Source Type: news

Adcetris Plus Chemo Effective in HIV-Related Hodgkin Lymphoma
(MedPage Today) -- Brentuximab vedotin (Adcetris) in combination with doxorubicin, vinblastine, and dacarbazine (AVD) was effective for patients with HIV-related stages II-IV classical Hodgkin lymphoma (cHL), according to results from the phase... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 4, 2023 Category: Hematology Source Type: news

Early Enthusiasm for Cancer Drug Reformulated for Ophthalmic Use
(MedPage Today) -- SEATTLE -- An ocular implant containing a reformulated cancer drug preserved vision and stabilized retinal thickening for up to a year while dramatically reducing treatment burden for neovascular age-related macular degeneration... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 2, 2023 Category: Hematology Source Type: news

AI-Backed Mammography Keeps Up With Docs for Cancer Detection
(MedPage Today) -- Artificial intelligence-supported mammography resulted in a cancer detection rate comparable to that of two breast radiologists working together, while also substantially cutting screening workload. Among more than 80,000 women... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 2, 2023 Category: Hematology Source Type: news

Adjuvant Everolimus Falls Short in High-Risk Renal Cancer
(MedPage Today) -- Adjuvant everolimus (Afinitor) failed to significantly improve recurrence-free survival (RFS) in patients with renal cell carcinoma (RCC) who were at high risk for recurrence after nephrectomy, according to results from a randomized... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 31, 2023 Category: Hematology Source Type: news

Adjuvant Everolimus Falls Short in High-Risk Kidney Cancer
(MedPage Today) -- Adjuvant everolimus (Afinitor) failed to significantly improve recurrence-free survival (RFS) in patients with renal cell carcinoma (RCC) who were at high risk for recurrence after nephrectomy, according to results from a randomized... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 31, 2023 Category: Hematology Source Type: news

Elderly Man Develops Facial Plaque After Salivary Duct Carcinoma Diagnosis
(MedPage Today) -- Clinicians consider a number of differential diagnoses before making the call (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 31, 2023 Category: Hematology Source Type: news